首页> 外文期刊>American Journal of Kidney Diseases: The official journal of the National Kidney Foundation >Risk factors for mortality in infants and young children on dialysis.
【24h】

Risk factors for mortality in infants and young children on dialysis.

机译:透析中婴幼儿死亡的危险因素。

获取原文
获取原文并翻译 | 示例
           

摘要

The factors associated with a greater mortality risk in infants and young children undergoing dialysis have not been clearly determined. We report the results of a North American Pediatric Renal Transplant Cooperative Study designed to assess risk factors in patients aged younger than 6 years at initiation of dialysis therapy. Sixty-four nonsurvivors were matched with 110 survivors for age at dialysis initiation, primary renal disease, and year of entry onto the database. Questionnaires on 137 patients (51 nonsurvivors, 86 survivors) were completed by participating centers. Seventy-five percent (103 of 137 patients) of the patients were aged younger than 2 years at dialysis initiation; 42% (58 of 137 patients) had renal aplasia, dysplasia, and/or hypoplasia or obstructive uropathy; 62% were boys; and 62% were white. One-year patient survival rates were 83% in infants beginning dialysis at younger than 3 months of age, 89% in 3- to 23-month-olds, and 95% in 2- to 5-year-olds (P = 0.001). Comorbid nonrenal disease occurred in 37 of 51 nonsurvivors (74%) versus 46 of 84 survivors (55%; P = 0.027). Nonsurvivors had pulmonary disease and/or hypoplasia more often (14 of 37 nonsurvivors; 37.8% versus 8 of 46 survivors; 17.4%; P = 0.04). Oliguria or anuria was present in 23 of 33 nonsurvivors (70%) aged younger than 2 years versus 26 of 64 survivors (41%; P = 0.007). Infection accounted for 15 of 51 deaths (29.4%). In summary, these results suggest that age at dialysis initiation; presence of nonrenal disease, particularly pulmonary disease and/or hypoplasia; and oliguria or anuria in children aged younger than 2 years are identifiable as risk factors for mortality in these young patients.
机译:尚未明确确定与接受透析的婴幼儿较高的死亡风险相关的因素。我们报告了一项北美儿科肾脏移植合作研究的结果,该研究旨在评估透析治疗开始时年龄小于6岁的患者的危险因素。在透析开始,原发性肾脏疾病和进入数据库的年份,将64名非幸存者与110名幸存者配对。参与中心完成了对137例患者的问卷调查(51名非幸存者,86名幸存者)。透析开始时有75%(137位患者中的103位)年龄小于2岁。 42%(137位患者中的58位)患有肾发育不全,发育不良和/或发育不全或阻塞性尿路病; 62%是男孩;白色的占62%。 3个月以下开始透析的婴儿的一年患者存活率为83%,3到23个月大的婴儿为89%,2到5岁的婴儿为95%(P = 0.001) 。 51例非幸存者中有37例发生共病性非肾脏疾病(74%),而84例幸存者中有46例(55%; P = 0.027)。非幸存者罹患肺部疾病和/或发育不全的频率更高(37个非幸存者中有14个; 37.8%比46个幸存者中的8个; 17.4%; P = 0.04)。年龄小于2岁的33名非幸存者中有23名(70%)存在少尿或无尿,而64名幸存者中有26名(41%; P = 0.007)。感染占51例死亡中的15例(29.4%)。总之,这些结果表明透析开始时的年龄。存在非肾脏疾病,特别是肺部疾病和/或发育不全; 2岁以下儿童的尿少和无尿可确定为这些年轻患者死亡的危险因素。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号